Cellix Bio innovative platform
an effective methodology to drug design that focuses on creating new molecular entities with improved pharmacokinetic profile and synergistic pharmacology. Synergix aims to target known biomolecular pathophysiological pathways considered likely to yield significant therapeutic benefits as well as developing the structural molecular chemistry to optimize the New Molecular Entities (NMEs).
The NMEs are designed to be cleaved by specific enzymes exclusively within cells or by the mediation of specific intestinal enzymes in order to release the two bioactives independently and, therefore allowing the bioactives to reach their targets more efficiently and have greater efficacy and better PK-PD profile than if the bioactives were dosed independently or in combination.
Selective established drugs transformation utilizing long chain fatty acid chemistry to enhance their molecular profile, augment pharmacological and disease modifying potential.